HomeALA • ASX
add
Arovella Therapeutics Ltd
Previous close
$0.19
Day range
$0.19 - $0.19
Year range
$0.080 - $0.21
Market cap
192.83M AUD
Avg Volume
1.76M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Investing.com
4 minutes ago
S&P 500 having same returns in 2025 as achieved in 2024 'may be difficult'
0.00%
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 4.25K | -67.69% |
Operating expense | 2.43M | 2.16% |
Net income | -2.40M | 23.59% |
Net profit margin | -56.47K | -136.51% |
Earnings per share | — | — |
EBITDA | -2.42M | -1.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.71M | 145.67% |
Total assets | 13.28M | 142.82% |
Total liabilities | 2.06M | 21.63% |
Total equity | 11.23M | — |
Shares outstanding | 1.05B | — |
Price to book | 18.70 | — |
Return on assets | -45.66% | — |
Return on capital | -54.03% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.40M | 23.59% |
Cash from operations | -2.14M | -13.36% |
Cash from investing | -47.35K | -199.24% |
Cash from financing | 6.16M | 130.76% |
Net change in cash | 3.98M | 377.94% |
Free cash flow | -1.30M | -6.73% |
About
Founded
1999
Website
Employees
27
